246 results on '"Auriemma, Renata S"'
Search Results
2. Insulina settimanale Icodec nel diabete tipo 2: una prospettiva concreta
3. Acromegalia e neoplasie intraduttali papillari mucinose del pancreas
4. Prolattinomi in gravidanza: gestione clinica
5. The Role of the Environment in Testicular Dysgenesis Syndrome
6. Clinical Case 1
7. Risk Assessment of Diabetes Mellitus During and After Pregnancy in Women With Prolactinomas.
8. Terapia dei prolattinomi: quando sospendere?
9. Investigational drugs for the Treatment of Acromegaly: new agents to transform therapy
10. Pregnancy in prolactinomas: clinical management
11. Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting
12. Metabolic effects of prolactin
13. Approach to the Patient With Prolactinoma
14. Fertility in Acromegaly: a single center experience on female patients during active disease and after disease remission
15. Cabergoline Use for Pituitary Tumors and Valvular Disorders
16. Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly
17. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
18. Le forme familiari di adenoma ipofisario
19. Acromegaly and Changes in Growth Parameters: A Focus on Cardiovascular, Metabolic, Respiratory Abnormalities, Malignancies, and Bone Alterations
20. Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
21. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
22. Editorial: Resistance to Medical Therapy in Pituitary Tumors
23. Trattamento di un prolattinoma aggressivo con temozolomide: case report e revisione della letteratura
24. Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status
25. Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
26. Familial isolated pituitary adenomas
27. Hyperprolactinemia after menopause: Diagnosis and management
28. Fertility in acromegaly: A single center experience on female patients during active disease and after disease remission
29. The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life
30. Medical consequences of acromegaly: What are the effects of biochemical control?
31. Gli analoghi della somatostatina nel trattamento degli adenomi ipofisari non GH-secernenti
32. Acromegaly and Changes in Growth Parameters: A Focus on Cardiovascular, Metabolic, Respiratory Abnormalities, Malignancies, and Bone Alterations
33. Long-Term Treatment with Somatostatin Analogs in Acromegaly Increases Life Expectancy. A Comparative Study in Bulgaria and Campania (Italy)
34. Impact of Germline AIP Mutations on Tumor Characteristics and Management in Young Acromegalic Patients: Results of an Age- and Tumor-Diameter-Matched Cohort Study
35. Results of a Single-Center Observational 10-Year Survey Study on Recurrence of Hyperprolactinemia after Pregnancy and Lactation
36. Resistance to Somatostatin Analogs in Acromegaly
37. Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects
38. Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?
39. The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology
40. Pasireotide-induced hyperglycemia and efficacy of antidiabetic treatments in patients with acromegaly: Evaluation of two referral centers
41. Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study
42. Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study
43. Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegaly
44. Impact of Somatostatin Analogs Versus Surgery on Glucose Metabolism in Acromegaly: Results of a 5-Year Observational, Open, Prospective Study
45. Growth Hormone-Secreting Tumor Shrinkage after 3 Months of Octreotide-Long-Acting Release Therapy Predicts the Response at 12 Months
46. Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
47. The Association of Fasting Insulin Concentrations and Colonic Neoplasms in Acromegaly: A Colonoscopy-Based Study in 210 Patients
48. Treatment with Growth Hormone Receptor Antagonist in Acromegaly: Effect on Cardiac Structure and Performance
49. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly
50. Predictors of Tumor Shrinkage after Primary Therapy with Somatostatin Analogs in Acromegaly: A Prospective Study in 99 Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.